Rhythm Pharmaceuticals Q4 EPS $(0.70) Misses $(0.69) Estimate, Sales $24.23M Miss $25.38M Estimate

Author: Benzinga Newsdesk | February 22, 2024 08:05am
Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.69) by 1.45 percent. This is a 6.67 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $24.23 million which missed the analyst consensus estimate of $25.38 million by 4.52 percent. This is a 175.70 percent increase over sales of $8.79 million the same period last year.

Posted In: RYTM